I n their report, Albers et al. 1 present data on the potential clinical utility of immunohistochemical expression of Ki-67 in clinical Stage I nonseminomatous testicular germ cell tumors (NSGCT) to predict a group of patients at low risk for occult metastatic disease. Using a cutoff value of Γ΅70% M
β¦ LIBER β¦
Prognostic risk factors in low stage testicular germ cell tumors : Unanswered questions regarding clinically useful prognosticators for extratesticular disease
β Scribed by Harry W. Herr
- Publisher
- John Wiley and Sons
- Year
- 1998
- Tongue
- English
- Weight
- 52 KB
- Volume
- 82
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Prognostic risk factors in low stage tes
β
Axel Heidenreich; Isabell A. Sesterhenn; Judd W. Moul
π
Article
π
1997
π
John Wiley and Sons
π
English
β 67 KB
π 1 views
Prognostic risk factors in low stage tes
β
Peter Albers; Erhard Bierhoff; Daniela Neu; Rolf Fimmers; Nicolas Wernert; Stefa
π
Article
π
1997
π
John Wiley and Sons
π
English
β 32 KB
π 1 views
Prognostic risk factors that identify pa
β
Axel Heidenreich; Isabell A. Sesterhenn; F. Kash Mostofi; Judd W. Moul
π
Article
π
1998
π
John Wiley and Sons
π
English
β 98 KB
π 1 views
## Background: The purpose of this study was to develop a reliable model to identify clinical stage i nonseminomatous germ cell tumors (nsgcts) associated with low risk or high risk for occult retroperitoneal metastasis, so that the model could be used to customize the therapeutic approach for pati